tiprankstipranks
Incyte Corp (INCY)
NASDAQ:INCY

Compare Incyte (INCY) vs. Competitors

1,917 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Incyte
$96.07
$19.12B
14.98
74.13%
8 Buy
8 Hold
1 Sell
Moderate Buy
BioMarin Pharmaceutical
$54.53
$10.49B
32.67
-3.18%
13 Buy
3 Hold
0 Sell
Strong Buy
Exelixis
$44.27
$11.50B
12.10
28.47%
7 Buy
7 Hold
1 Sell
Moderate Buy
United Therapeutics
$571.73
$25.06B
16.17
105.00%
10 Buy
4 Hold
0 Sell
Moderate Buy
Ascendis Pharma
$239.28
$14.69B
-50.22
66.94%
13 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$28.25
$17.31B
19.86
56.86%
8 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INCY
Incyte
96.07
36.85
62.23%
BMRN
BioMarin Pharmaceutical
54.53
-5.14
-8.61%
EXEL
Exelixis
44.27
8.53
23.87%
UTHR
United Therapeutics
571.73
287.42
101.09%
ASND
Ascendis Pharma
239.28
83.78
53.88%
GMAB
Genmab
28.25
8.93
46.22%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts